Please enable JavaScript to continue using this application.

Compare $LEGN vs $VKTX | Chartloom

Compare

$LEGN vs $VKTX

Legend Biotech Corp · Viking Therapeutics Inc

LEGN

Legend Biotech Corp

VKTX

Viking Therapeutics Inc

Compare $LEGN vs $VKTX

Comparing Legend Biotech Corp and Viking Therapeutics Inc

LEGNLegend Biotech Corp

VKTXViking Therapeutics Inc

LEGNLegend Biotech Corp

Market cap

$3.62B

P/E (TTM)

—

Forward P/E (NTM)

25.42x

Forward P/S (NTM)

2.17x

Rev growth (TTM)

59.6%

YTD performance

-13.4%

52W performance

-42.2%

FCF yield

-3.4%

VKTXViking Therapeutics Inc

Market cap

$3.33B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-19.5%

52W performance

-11.9%

FCF yield

-12.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LEGN

VKTX

Detailed metrics comparison

LEGN

Legend Biotech Corp

VKTX

Viking Therapeutics Inc

Market Cap

LEGN$3.62B

VKTX$3.33B

Enterprise Value

LEGN$3.23B

VKTX$3.20B

Price

LEGN$18.62

VKTX$28.51

P/E Ratio

LEGNN/A

VKTXN/A

P/S Ratio

LEGN2.85x

VKTX0.00x

EV/Sales

LEGN2.54x

VKTX0.00x

EV/EBITDA

LEGN0.00x

VKTX0.00x

P/B Ratio

LEGN3.04x

VKTX9.38x

P/FCF Ratio

LEGNN/A

VKTXN/A

EV/FCF

LEGN-26.50x

VKTX-7.65x

PEG Ratio

LEGNN/A

VKTXN/A

Forward P/E (NTM)

LEGN25.42x

VKTXN/A

Forward P/S (NTM)

LEGN2.17x

VKTXN/A

Revenue (TTM)

LEGN$1.27B

VKTX$0

Revenue Growth (YoY)

LEGN59.6%

VKTXN/A

Forward Rev Growth

LEGN25.0%

VKTX236.5%

Gross Margin (TTM)

LEGN56.6%

VKTX0.0%

Operating Margin (TTM)

LEGN0.0%

VKTX0.0%

EBITDA Margin (TTM)

LEGN-0.8%

VKTX0.0%

Net Margin (TTM)

LEGN-7.2%

VKTX0.0%

FCF Margin (TTM)

LEGN-9.6%

VKTXN/A

Net Income (TTM)

LEGN$-92M

VKTX$-535M

FCF (TTM)

LEGN$-122M

VKTX$-418M

EPS (TTM)

LEGN-$0.47

VKTX-$4.60

ROE (TTM)

LEGN-870.0%

VKTX-9456.0%

ROA (TTM)

LEGN-539.0%

VKTX-8274.0%

ROIC (TTM)

LEGN-643.0%

VKTX-9456.0%

Cash

LEGN$673M

VKTX$126M

Debt

LEGN$278M

VKTX$0

Net Cash/Debt

LEGN$395M

VKTX$126M

Current Ratio (TTM)

LEGN3.04x

VKTX4.72x

Quick Ratio (TTM)

LEGN2.89x

VKTX4.57x

Debt/Equity (TTM)

LEGN0.23x

VKTX0.00x

Debt/Assets (TTM)

LEGN0.0%

VKTX0.0%

Interest Coverage (TTM)

LEGNN/A

VKTXN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

VKTX0.00x

Beta

LEGN0.57

VKTX0.69

52W Performance

LEGN-42.2%

VKTX-11.9%

YTD Performance

LEGN-13.4%

VKTX-19.5%

% from 52W High

LEGN-50.3%

VKTX-33.9%

% from 52W Low

LEGN14.7%

VKTX10.6%

Asset Turnover (TTM)

LEGN0.75x

VKTX0.00x

FCF Yield (TTM)

LEGN-3.4%

VKTX-12.6%

Earnings Yield (TTM)

LEGN-2.5%

VKTX-16.1%

Dividend Yield (TTM)

LEGNN/A

VKTXN/A

Rule of 40

LEGN50.0

VKTX0.0

EV/GP/RG

LEGN0.13

VKTXN/A

Ticker research

View LEGN research View VKTX research

Metric	LEGN Legend Biotech Corp	VKTX Viking Therapeutics Inc
Market & Valuation
Market Cap	$3.62B	$3.33B
Enterprise Value	$3.23B	$3.20B
Price	$18.62	$28.51
P/E Ratio	N/A	N/A
P/S Ratio	2.85x	0.00x
EV/Sales	2.54x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.04x	9.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.50x	-7.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.42x	N/A
Forward P/S (NTM)	2.17x	N/A
Revenue & Growth
Revenue (TTM)	$1.27B	$0
Revenue Growth (YoY)	59.6%	N/A
Forward Rev Growth	25.0%	236.5%
Profitability
Gross Margin (TTM)	56.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.8%	0.0%
Net Margin (TTM)	-7.2%	0.0%
FCF Margin (TTM)	-9.6%	N/A
Net Income (TTM)	$-92M	$-535M
FCF (TTM)	$-122M	$-418M
EPS (TTM)	-$0.47	-$4.60
ROE (TTM)	-870.0%	-9456.0%
ROA (TTM)	-539.0%	-8274.0%
ROIC (TTM)	-643.0%	-9456.0%
Financial Health
Cash	$673M	$126M
Debt	$278M	$0
Net Cash/Debt	$395M	$126M
Current Ratio (TTM)	3.04x	4.72x
Quick Ratio (TTM)	2.89x	4.57x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	0.69
52W Performance	-42.2%	-11.9%
YTD Performance	-13.4%	-19.5%
% from 52W High	-50.3%	-33.9%
% from 52W Low	14.7%	10.6%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.00x
FCF Yield (TTM)	-3.4%	-12.6%
Earnings Yield (TTM)	-2.5%	-16.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	0.0
EV/GP/RG	0.13	N/A
Ticker research	View LEGN research	View VKTX research

Valuation

P/S Ratio

VKTX

0.00x

LEGN

2.85x

EV/FCF

LEGN

-26.50x

VKTX

-7.65x

Growth & revenue

Revenue Growth TTM

LEGN

59.6%

Forward Revenue Growth

VKTX

236.5%

LEGN

25.0%

Profitability & performance

Gross Margin

LEGN

56.6%

VKTX

0.0%

ROE

LEGN

-870.0%

VKTX

-9456.0%

FCF Yield %

LEGN

-3.4%

VKTX

-12.6%

52-Week Performance

VKTX

-11.9%

LEGN

-42.2%

Detailed metrics comparison

LEGN

Legend Biotech Corp

VKTX

Viking Therapeutics Inc

Market Cap

LEGN$3.62B

VKTX$3.33B

Enterprise Value

LEGN$3.23B

VKTX$3.20B

Price

LEGN$18.62

VKTX$28.51

P/E Ratio

LEGNN/A

VKTXN/A

P/S Ratio

LEGN2.85x

VKTX0.00x

EV/Sales

LEGN2.54x

VKTX0.00x

EV/EBITDA

LEGN0.00x

VKTX0.00x

P/B Ratio

LEGN3.04x

VKTX9.38x

P/FCF Ratio

LEGNN/A

VKTXN/A

EV/FCF

LEGN-26.50x

VKTX-7.65x

PEG Ratio

LEGNN/A

VKTXN/A

Forward P/E (NTM)

LEGN25.42x

VKTXN/A

Forward P/S (NTM)

LEGN2.17x

VKTXN/A

Revenue (TTM)

LEGN$1.27B

VKTX$0

Revenue Growth (YoY)

LEGN59.6%

VKTXN/A

Forward Rev Growth

LEGN25.0%

VKTX236.5%

Gross Margin (TTM)

LEGN56.6%

VKTX0.0%

Operating Margin (TTM)

LEGN0.0%

VKTX0.0%

EBITDA Margin (TTM)

LEGN-0.8%

VKTX0.0%

Net Margin (TTM)

LEGN-7.2%

VKTX0.0%

FCF Margin (TTM)

LEGN-9.6%

VKTXN/A

Net Income (TTM)

LEGN$-92M

VKTX$-535M

FCF (TTM)

LEGN$-122M

VKTX$-418M

EPS (TTM)

LEGN-$0.47

VKTX-$4.60

ROE (TTM)

LEGN-870.0%

VKTX-9456.0%

ROA (TTM)

LEGN-539.0%

VKTX-8274.0%

ROIC (TTM)

LEGN-643.0%

VKTX-9456.0%

Cash

LEGN$673M

VKTX$126M

Debt

LEGN$278M

VKTX$0

Net Cash/Debt

LEGN$395M

VKTX$126M

Current Ratio (TTM)

LEGN3.04x

VKTX4.72x

Quick Ratio (TTM)

LEGN2.89x

VKTX4.57x

Debt/Equity (TTM)

LEGN0.23x

VKTX0.00x

Debt/Assets (TTM)

LEGN0.0%

VKTX0.0%

Interest Coverage (TTM)

LEGNN/A

VKTXN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

VKTX0.00x

Beta

LEGN0.57

VKTX0.69

52W Performance

LEGN-42.2%

VKTX-11.9%

YTD Performance

LEGN-13.4%

VKTX-19.5%

% from 52W High

LEGN-50.3%

VKTX-33.9%

% from 52W Low

LEGN14.7%

VKTX10.6%

Asset Turnover (TTM)

LEGN0.75x

VKTX0.00x

FCF Yield (TTM)

LEGN-3.4%

VKTX-12.6%

Earnings Yield (TTM)

LEGN-2.5%

VKTX-16.1%

Dividend Yield (TTM)

LEGNN/A

VKTXN/A

Rule of 40

LEGN50.0

VKTX0.0

EV/GP/RG

LEGN0.13

VKTXN/A

Ticker research

View LEGN research View VKTX research

Metric	LEGN Legend Biotech Corp	VKTX Viking Therapeutics Inc
Market & Valuation
Market Cap	$3.62B	$3.33B
Enterprise Value	$3.23B	$3.20B
Price	$18.62	$28.51
P/E Ratio	N/A	N/A
P/S Ratio	2.85x	0.00x
EV/Sales	2.54x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.04x	9.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.50x	-7.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.42x	N/A
Forward P/S (NTM)	2.17x	N/A
Revenue & Growth
Revenue (TTM)	$1.27B	$0
Revenue Growth (YoY)	59.6%	N/A
Forward Rev Growth	25.0%	236.5%
Profitability
Gross Margin (TTM)	56.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.8%	0.0%
Net Margin (TTM)	-7.2%	0.0%
FCF Margin (TTM)	-9.6%	N/A
Net Income (TTM)	$-92M	$-535M
FCF (TTM)	$-122M	$-418M
EPS (TTM)	-$0.47	-$4.60
ROE (TTM)	-870.0%	-9456.0%
ROA (TTM)	-539.0%	-8274.0%
ROIC (TTM)	-643.0%	-9456.0%
Financial Health
Cash	$673M	$126M
Debt	$278M	$0
Net Cash/Debt	$395M	$126M
Current Ratio (TTM)	3.04x	4.72x
Quick Ratio (TTM)	2.89x	4.57x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	0.69
52W Performance	-42.2%	-11.9%
YTD Performance	-13.4%	-19.5%
% from 52W High	-50.3%	-33.9%
% from 52W Low	14.7%	10.6%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.00x
FCF Yield (TTM)	-3.4%	-12.6%
Earnings Yield (TTM)	-2.5%	-16.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	0.0
EV/GP/RG	0.13	N/A
Ticker research	View LEGN research	View VKTX research